5 Stocks Least Vulnerable to Recession
Amgen, Inc. (NASDAQ:AMGN) discovers, develops, manufactures, and delivers human therapeutics worldwide.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 1,661,700 | $404,292 | -4% | 1.14% |
| 2. | 1,536,900 | $373,928 | +43% | 0.09% | |
| 3. | Renaissance Technologies Jim Simons | 1,439,745 | $350,290 | +280% | 0.41% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,365,702 | $332,275 | +3% | 0.47% |
| 5. | 1,344,800 | $327,190 | +4% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | Director | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | Director | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | Officer, Director | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $249.00 | 6,600 | Director | 21,184 | 2022-08-18 | Filing | |
| $250.00 | 600 | Director | 5,501 | 2022-05-23 | Filing | |
| $241.81 | 13,500 | Officer | 37,333 | 2022-05-10 | Filing | |
| $252.51 | 2,500 | Officer | 12,461 | 2021-05-11 | Filing | |
| $250.59 | 1,000 | Director | 15,927 | 2021-05-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 3,496,997 | $850,819,371 | 0.44% | |
| 2. | 783,820 | $190,703,406 | 0.29% | |
| 3. | 2,234 | $54,353,220 | 0.08% | |
| 4. | 147,415 | $35,866,070 | 0.25% | |
| 5. | 111,381 | $27,098,997 | 0.24% |
News See All
5 Best Dividend Stocks to Buy in 2022
In this article, we discuss 5 best dividend stocks to buy in 2022.
Dow 30 Stocks Listed and Ranked By 2022 Hedge Fund Bullishness Index
In this article, we discuss the Dow 30 stocks and their rank according to the 2022 hedge fund bullishness index.
11 Stocks Making Big Moves on Earnings Reports
In this article, we will take a look at the 11 stocks making big moves on earnings reports.
10 Dividend Stocks to Buy Now According to Kerr Neilson's Hedge Fund
In this article, we will discuss 10 dividend stocks to buy now according to Kerr Neilson's hedge fund.
5 Best Pharmaceutical Stocks to Buy in 2022
In this article, we discuss the 5 best pharmaceutical stocks to buy in 2022.
5 Best Dividend Stocks According to Billionaire Larry Robbins' Glenview Capital
In this article, we discuss the 5 best dividend stocks according to billionaire Larry Robbins' Glenview Capital.
5 Stocks On Investors' Radar After Earnings Reports
In this article, we discuss the 5 stocks on investors' radar after earnings reports.
5 Stocks for Dividend Growth Investing in 2022
In this article, we discuss 5 stocks for dividend growth investing in 2022.
Was The Smart Money Right About Amgen, Inc. (AMGN)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Billionaire Hedge Funds
